B02 LL (Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg)

Pill imprint B02 LL has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg.

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for B02 LL

Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg B02 LL
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg B02 LL Front
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg B02 LL Back
Hydrochlorothiazide and lisinopril
Imprint:
B02
LL
Strength:
12.5 mg / 20 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lupin Pharmaceuticals, Inc
National Drug Code (NDC):
68180-0519
Inactive Ingredients:
calcium phosphate dibasic anhydrous
ferric oxide yellow
mannitol
corn starch
magnesium stearate
pregelatinized corn starch

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)